Search Results

Filter
  • 1-10 of  21 results for ""Receptor, EphA2""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R level.

  • Authors : Jørgensen SH; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.; Global Research Technologies, Novo Nordisk A/S, 2760, Maaloev, Denmark.

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Receptor, IGF Type 1*/Receptor, IGF Type 1*/Receptor, IGF Type 1*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Nov 21; Vol. 14 (1), pp. 28856. Date of Electronic Publication: 2024 Nov 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma.

  • Authors : Kim HS; Department of Gastric Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.; Won YJ

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*metabolism ; Receptor, EphA2/Receptor, EphA2/Receptor, EphA2/*metabolism ; Stomach Neoplasms/Stomach Neoplasms/Stomach Neoplasms/*metabolism

  • Source: Scientific reports [Sci Rep] 2019 Mar 04; Vol. 9 (1), pp. 3414. Date of Electronic Publication: 2019 Mar 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.

  • Authors : Mercurio FA; Institute of Biostructures and Bioimaging (IBB), CNR, via Mezzocannone 16, 80134, Naples, Italy.; Di Natale C

Subjects: Sterile Alpha Motif*/Sterile Alpha Motif*/Sterile Alpha Motif*/drug effects; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/*antagonists & inhibitors ; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/*metabolism

  • Source: Scientific reports [Sci Rep] 2017 Dec 12; Vol. 7 (1), pp. 17474. Date of Electronic Publication: 2017 Dec 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A new autoinhibited kinase conformation reveals a salt-bridge switch in kinase activation.

  • Authors : Wei Q; College of Chemistry, Beijing Normal University, Beijing, 100875, China.; Yang S

Subjects: Magnesium/Magnesium/Magnesium/*metabolism ; Receptor, EphA2/Receptor, EphA2/Receptor, EphA2/*metabolism; Crystallography, X-Ray

  • Source: Scientific reports [Sci Rep] 2016 Jun 21; Vol. 6, pp. 28437. Date of Electronic Publication: 2016 Jun 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.

  • Authors : Jukonen J; Translational Cancer Medicine Research Program, University of Helsinki, 00140, Helsinki, Finland.; Moyano-Galceran L

Subjects: Neoplasm Recurrence, Local* ; Up-Regulation*; Ephrin-A5/Ephrin-A5/Ephrin-A5/*metabolism

  • Source: Scientific reports [Sci Rep] 2021 Apr 23; Vol. 11 (1), pp. 8856. Date of Electronic Publication: 2021 Apr 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Functional non-coding polymorphism in an EPHA2 promoter PAX2 binding site modifies expression and alters the MAPK and AKT pathways.

  • Authors : Ma X; Laboratory of Developmental Cell Biology and Disease, School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, 325003, China. .; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD, 20892, USA. .

Subjects: Polymorphism, Single Nucleotide* ; Promoter Regions, Genetic* ; Signal Transduction*

  • Source: Scientific reports [Sci Rep] 2017 Aug 30; Vol. 7 (1), pp. 9992. Date of Electronic Publication: 2017 Aug 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer.

  • Authors : Chu M; Department of Urology, The Second Affiliated Hospital, Harbin Medical University, 246 Xuefu St., Nan Gang District, Harbin, China. .; Zhang C

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*administration & dosage ; Endothelial Cells/Endothelial Cells/Endothelial Cells/*drug effects ; Leflunomide/Leflunomide/Leflunomide/*administration & dosage

  • Source: Scientific reports [Sci Rep] 2018 Jan 24; Vol. 8 (1), pp. 1539. Date of Electronic Publication: 2018 Jan 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  21 results for ""Receptor, EphA2""